Navigation Links
USC and second sight announce European clinical trial for Argus II retinal implant
Date:2/15/2008

Boston, MA, February 15, 2008 USC and Second Sight Medical Products Inc, leading developers of retinal prostheses for treating blindness, announced today that they have completed enrollment of the first phase of a U.S .FDA approved clinical study of the Argus II Retinal Prosthesis System. They also announced that enrollment at key European sites is underway as studies continue in Mexico.

We are pleased that Second Sight, along with our fantastic clinical partners, was able to fully enroll the US trial in a timely manner, said Robert Greenberg, MD, PhD, President and CEO of Second Sight, and a leader in the field of retinal prostheses for more than 15 years.

Although it is too early to comment on the clinical data, each device continues to function as expected, and all participants are using their systems at home daily.

The Argus II is the second generation of an electronic retinal implant designed for the treatment of blindness due to Retinitis Pigmentosa (RP), a group of inherited eye diseases that affect the retina. The Argus II implant consists of an array of 60 electrodes that are attached to the retina. These electrodes conduct information acquired from an external camera to the retina to provide a rudimentary form of sight to implanted subjects.

The development of this technology was largely supported by the National Eye Institute (NEI) of the National Institutes of Health (NIH), and the Department of Energys Office of Science (DOE) Artificial Retina Project, which is helping to advance the implants design and construction. The unique resources and expertise at DOE national laboratoriesparticularly in engineering, microfabrication, material science, and microelectronic technologiesare enabling the development of much smaller, higher resolution devices.

Ten subjects were recruited for the Phase I trial at four leading ophthalmic centers throughout the US, including the Doheny Eye Institute at the Univer
'/>"/>

Contact: Jon Weiner
jon.weiner@usc.edu
323-442-2830
University of Southern California
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related biology technology :

1. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
2. OncoGenex reports lead drug candidate OGX-011 achieved primary endpoint in Phase 2 Trial with second-line chemotherapy for prostate cancer
3. Escalon(R) Reports Second Quarter Fiscal 2008 Results
4. Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results
5. Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST
6. Update: Neurobiological Technologies Sets Date for Second Quarter Financial Results and Conference Call
7. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
8. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
9. Palatin Technologies to Report Second Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on February 11th
10. Nutrition 21 to Report Second Quarter Fiscal 2008 Financial Results Monday, February 11, 2008
11. Neurobiological Technologies Sets Date for Second Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...ewswire/ -- Cromoz Inc., located in Research Trian...ube-based cancer drug delivery system in Hyderabad... have functional groups on the walls that allows f... partnership with the Indian Institute of Kanpur (...drug delivery vehicle with the ability to target t...
(Date:11/27/2009)... dye test alternative is helping bring complete a...closer for pharma-companies. It is a non-destructi...y Sepha for use with blister packs and it has al...harma-companies such as Sanofi-Avenis and Zydus-Ca...y improvements on the packaging line. Blistersca...
(Date:11/25/2009)...ewswire/ -- Research Triangle Park-based Cnanoz In...atment water purification system NanoPure(TM) deve...ister of Rural Water Supply, Hon. Minister Viswaru...tial tests, performed at Indian Institute of Techn... the drinking water available in India contains to...
(Date:11/25/2009)...k at Economic Club of Canada , ... Ambassador to Speak at Economic Club of Canada., ...nternational Investment, and Chairman and CEO of t... David Appia go to www.investinfrance.org . , , ... press to discuss recent pro-business initiatives ...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2
...O, Sept. 18 /PRNewswire/ - Trillium Therapeutics I...ecializing in the development of,innovative therap...,announced today that it has secured $12 million i...owth Private Equity Partners, BDC Capital and,Cana...rtunate to have the continued support of some of C...
... JD Technologies, LLC will use...shed relationships in numerous industries to pursu...amic manufacturing design, development and testing...sachusetts (PRWEB) September 18, 2008 -- JD Techno...FCT, an established manufacturer of a broad variet...
... Pa., Sept. 17 BioTrends Research Group, Inc.,rel...e of Biologic Agents,in Rheumatology publication, ...d Arthritis (RA), Psoriatic Arthritis (PsA), and A...n responses to an online survey,completed by 100 U...he study, the majority of Rheumatologists reported...
Other Biology Technology:Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway 2JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States 2JD Technologies, LLC Selected by FCT Ingenieurkeramik GmbH to Represent Their High Performance Ceramic Expertise In the United States 3Use of Biologic Agents Continues to Expand Among US Rheumatologists - Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis? 2
(Date:11/23/2009)... , Farmington, CT Current research suggests that... disease. The related report by Nichols et al, "U...nt a New Class of TLR2 Ligands Capable of Enhancin...e of The American Journal of Pathology . , Mult...stem attacks the brain and spinal cord, affects ne...
(Date:11/23/2009)... , , AMES, Iowa - The only swine vaccine availabl...swine herd infected with the virus. The vaccinatio...swine herd diagnosed with the pandemic flu., Iow...mal science, developed the vaccine this summer and...cers in Iowa, Kansas and Illinois for several week...
(Date:11/23/2009)... , MADISON, WI, November 16, 2009 -- A USDOE and ... cropland, idle cropland, and cropland pasture cou...n of perennial grasses, such as switchgrass, from ...uel feedstock. Economically viable production of a...l quantities of biomass are removed annually is ex...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2BodySculpt 28TM 29 Leads FDA Approval of BodyTite 28TM 29 with Largest Number of Documented Study Cases 5012 1BodySculpt 28TM 29 Leads FDA Approval of BodyTite 28TM 29 with Largest Number of Documented Study Cases 5012 2Soda Tax Wins Health Experts Support 57429 1Soda Tax Wins Health Experts Support 57429 2Soda Tax Wins Health Experts Support 57429 3Soda Tax Wins Health Experts Support 57429 4Nielsen Announces First Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC 57425 1Nielsen Announces First Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC 57425 2Nielsen Announces First Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC 57425 3
...om Queen,s University are in India today (Monday) ...ic infections which destroy plants and animals. , ... University are at the forefront of research into ... $200 billion in lost crop production and $5.3 bil...ed by Dr Gerry Brennan from the School of Biologic...
...ts funded by the Biotechnology and Biological Scie...scovery tool to identify a new player in the body,...ark a completely new class of drugs to treat type ...ry) in Nature Chemical Biology researchers at th...ited new technology to create a cheap and efficien...
...2, 2009--Researchers at the Dana-Farber Cancer Ins...l Research (Burnham) and the Centers for Disease C...tification of human monoclonal antibodies (mAb) th...A viruses, including avian influenza A (H5N1) viru...easonal influenza viruses. These antibodies have t...
Other Biology News:Reduction in parasite infections ahead for India 2Scientists mine drugs database for new diabetes treatment 2Scientists identify human monoclonal antibodies effective against bird, seasonal flu viruses 2Scientists identify human monoclonal antibodies effective against bird, seasonal flu viruses 3
BD IMagnet 1 each from BD Biosciences Pharmingen
CryoPlus Vertical Rack, CP-5-2-CW/100, 27-1/2" OAH from Thermo Scientific
...1997). • This book describes current strategi...ity antibodies, the use of antibodies in immunoass...s, the latest ELISA techniques including amplifica...ll-surface molecules (cell-ELISA and ELISPOT proce...
...kDa Formulation: 10mM HEPES, pH 7.4, 150mM NaCl, 0...l Properites: For Specific Activity data, refer to...f enzyme. Purification: ammonium salt precipitatio...hange chromatography Quality Assurance: routinely ...
Biology Products: